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Abstract: The novel 2-substituted-1,3,2-oxazaphosphole-2-oxides of (S)-(+)-prolinol were synthesized by the 
cyclization  of  (S)-(+)-prolinol  (3)  with  phosphorusoxychloride  (4)  followed  by  the  treatment  with  various 
phenolic compounds, aminoacid esters and amine (6a-l) to obtain the title compounds (7a-l). Their structures are 
characterized by spectral, elemental analyses and evaluated their in vitro antibacterial activity against two gram 
positive and two gram negative bacteria. Three compounds exhibited very significant anti bacterial activity when 
compared with that of Ciprofloxacin.  
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1. Introduction 
 
At  the  outset  a  wide  range  of  pesticides,  insecticides  and  antibiotics  emanated  from 
phosphorus compounds.
1 Specifically organophosphorus heterocycles bearing the P-N functionality 
exhibited  anti-tumor,  pesticidal  and  medicinal  activity.
2-4  Optically  active  organophosphorus 
compounds,  possessing  a  chiral  centre  at  phosphorus  are  known  to  exhibit  a  variety  of  unique 
biological activities and hence they have a potential use as agricultural chemicals.
5 The synthesis of 
multi–ring phosphorus heterocycles were accomplished much importance as they find applications in 
medicine  and  industry.
6 Similarly  the derivatives  of  aminoacids and  phenolic compounds  are  also 
potential physiologically active compounds and also it is reported that the  1,3,2-oxazaphospholes are 
biologically  important  in  the  sense  of  its  antimicrobial  activity  i.e.,  antifungal  and  antibacterial 
activity.
6 These aspects are driven to design and synthesis of title compounds as derivatives of (S)-(+) 
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prolinol as a part of our research and evaluation of their antibacterial activity for the first time. More 
over,  these  proline  based  oxazaborolidines  had  been  used  as  catalysts  by  Corey  for  the  borane-
mediated enantioselective reduction of prochiral ketones , a plethora of oxazaborolidines and related 
catalysts based on various chiral pool sources have been developed and their applications have been 
well studied.
7-10 Simillarly proline-based phosphorylated derivatives were used for borane mediated 
reduction of prochiral α-halo ketones to α-halo alcohols.
11 It is noted that phosphorus compounds with 
N-P=O  structural  frame  work  containing  different  amino  and  phenolic  groups  on  phosphorus  as 
substituents  are  used  in  borane-mediated  asymmetric  reduction  of  prochiral  ketones  with  high 
enantiomeric purity, where the basic cyclic moiety controls the stereochemical course of the reaction, 
while the groups on the phosphorus have little significant role in directing the stereochemical course 
of the reaction.
11 Although we had studied the antibacterial activity of these compounds, we presume 
that  these  title  compounds  can  control  stereochemistry  in  organic  synthesis  as  chiral  catalysts  in 
further studies. 
 
2. Results and Discussion  
2.1. Chemistry 
 
2.1.1. Synthesis of 1,3,2-oxaza phosphole-2-oxides 
 
The  synthesis  of  novel  2-substituted-1,3,2-oxazaphosphole-2-oxides  of  (S)-(+)-prolinol  has 
accomplished in a two-step process. The (S)-(+)-prolinol (3) was treated with phosphorus oxychloride 
(4) in the presence of triethylamine in dry THF at -5 to 0 
oC for one hour to yield 2-chloro-1,3,2-
oxazaphosphole-2-oxide intermediate (5). To this intermediate (5) various phenols, aminoacid esters 
and amine (6a-l) were added in the presence of triethylamine in dry THF at 20 
oC. Then the reaction 
temperature was increased to 40-50 
oC and the reaction was continued for 5-6 hours to obtain the title 
compounds (7a-l). 
The  final  product  is  obtained  by  removing  the  triethylammonium  hydrochloride  salt  by 
filtration  and  evaporating  the  THF  solvent  in  a  rota-evaporator  and  finally  purified  by  column 
chromatography  and  characterized  by  spectral  and  elemental  analyses.  The  synthetic  pathway  is 
represented in Scheme- 1. 
 
2.1.2. Synthesis of (S)-(+)-Prolinol (2) 
 
The (S)-(+)-Prolinol (3), which is an α-aminoalcohol is prepared by the reduction of its α-
amino  acid  L-proline  (1)  by  converting  to  (S)-(+)-ethyl  prolinate  (2)  which  is  its  ester  and  then 
followed by reduction with lithium aluminium hydride at 0
oC in methanol.
 Further, it is characterized 
by determining its properties b.p. 54-56
oC, [ ]
25
D α  +38.6. The synthetic path is represented in Scheme-2. 
The chemical structures of all the title compounds 7a-l were characterized by IR, 
1H, 
13C, 
31P 
NMR,  mass  spectral  studies  and  elemental  analyses  and  their  data  are  presented  in  the  experimental 
section.  Characteristic  IR  stretching  absorptions  were  observed  in  the  regions  955-964  (P-O-CAr), 
1208-1220 (P-O-CAr), 1225-1251 (P=O), 1730-1754 (C=O) and 3326-3394 cm
-1 (N-H).
12 In 
1H NMR, 
the 3a proton resonated in the region 2.91- 3.20 as a multiplet.
13 In the 
13C NMR P-O-C-7 resonated as 
a singlet in the region δ 58.6-60.2. The α-carbon of the aminoacid ester group resonated at δ 59.8-52.6. 
The 
31P NMR chemical shifts are observed in the range of  δ -22.28 to +24.53 ppm.
14,15 
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Scheme 1. Synthesis of 2-substituted-1,3,2-oxazaphosphole-2-oxide derivatives of (S)-(+)-prolinol 
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Scheme 2. Synthesis of (S)-(+)-prolinol 
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2.2. Evaluation of Antibacterial Activity 
 
The minimum inhibitory concentration of the test compounds (7a-l) was evaluated against two 
types of Gram Positive and Gram negative bacteria. The experiments were run in triplicates and the 
average results are included in Table.1. Most of the compounds were found to be effective against the 
microorganisms tested and these MICs were compared with the standard drug ciprofloxacin. The MIC 
values of the test compounds are almost as low as that of the standard drug. 
 
 
Table 1.  Minimum Inhibitory Concentrations (MIC in µg/mL) of the compounds 7a-l 
 
  R  7a  7b  7c  7d  7e  7f  7g  7h  7i  7j  7k  7l 
BS  0.11  0.13  0.22  0.15  0.13  0.23  0.15  0.19  0.23  0.21  0.14  0.15  0.15 
SA  0.16  0.21  0.42  0.29  0.21  0.25  0.49  0.76  1.00  0.81  0.29  0.22  0.72 
KP  0.15  0.17  0.54  0.21  0.59  0.18  0.33  0.28  0.39  0.42  0.36  0.19  0.38 
EC  0.22  0.24  0.51  0.35  0.26  0.25  0.55  0.46  0.61  0.44  0.34  0.26  0.62 
 
R= Ciprofloxacin,   SA= Staphylococcus aureus; BS= Bacillus subtilis;  
KP= Klebsiella pneumoniae; EC= Escherichia coli;  
 
 
3. Conclusion 
 
In  summary,  a  series  of  novel  2-substituted-1,3,2-oxazaphosphole-2-oxides  (7a-l)  were 
synthesized and their minimum inhibitory concentrations were evaluated. 
 
4. Experimental 
 
4.1. Chemistry 
 
Chemicals were procured from Sigma-Aldrich, Merck and Lancaster, used as such without 
further purification. All solvents used for the spectroscopic and other physical studies were reagent 
grade  and  further purified by literature  methods.
16 Melting  points  (m.p.)  were  determined  using  a 
calibrated thermometer by Guna Digital Melting Point apparatus, expressed in degrees centigrade (°C) 
and  are  uncorrected.  Infrared  Spectra  (IR)  were  obtained  on  a  Perkin-Elmer  Model  281-B 
spectrophotometer.  Samples  were  analyzed  as  potassium  bromide  (KBr)  disks.  Absorptions  were 
reported in wave numbers (cm
-1). 
1H, 
13C and 
31P NMR spectra were recorded as solutions in DMSO-
d6 on a Bruker AMX 500 MHz spectrometer operating at 500 MHz for 
1H, 125 MHz for 
13C and 202 
MHz for 
31P NMR. The 
1H and 
13C chemical shifts were expressed in parts per million (ppm) with 
reference to tetramethylsilane (TMS) and 
31P chemical shifts to 85 % H3PO4. LCMS mass spectra 
were recorded on a Jeol SX 102 DA/600 Mass spectrometer. Elemental analysis was performed on 
Thermo Finnigan Insturment at University of Hyderabad, Hyderabad, INDIA. 
 
(3aS)-2-(4
l-chlorophenoxy)perhydro-2λ
5-pyrrolo[1,2-c][1,3,2]oxazaphosphol-2-one (7a): Yield: 72%; 
Mol.Wt: 273.5; m.p. 103-105 °C; 
lH NMR (500 MHz, DMSO-d6) (δ ppm): 7.51 (d, 2H, J= 8.2 Hz, H-
3
l &
 H-5
l), 7.10 (d, 2H, J= 8.5 Hz, H-2
l &
 H-6
l), 3.29-3.37 (m, 2H,
 H-7), 3.05-3.12 (m, 1H, H-3a), Satheesh Krishna et.al., Org. Commun. (2010) 3:4 98-105  
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2.80-2.87 (m, 2H, H-4), 1.42-1.63 (m, 4H, H-5
 &
 H-6);
  13C NMR (125 MHz, DMSO-d6) (δ ppm):  
149.1 (C-1
l),  130.1 (C-4
l), 127.6 (C-3
l & C-5
l), 125.8 (C-2
l & C-6
l), 58.6 (C-7), 47.8 (C-3a), 44.5 (C-
4), 33.2 (C-6), 27.1 (C-5); 
31P NMR (202 MHz, DMSO-d6) (δ ppm): 20.40; IR (KBr) cm
-1: 1247 
(P=O), 1208 (P-O-CAr), 961 (P-O-CAr); LCMS m/z (%): 275 [M+2] (27), 273[M
+•] (80), 190 (54), 146 
(37). Analysis (% calculated/ found) for C11H13ClNO3P: C: 48.26/ 48.22, H: 4.75/ 4.72, N: 5.11/ 5.07. 
 
(3aS)-2-(4
l-nitrophenoxy)perhydro-2λ
5-pyrrolo[1,2-c][1,3,2]oxazaphosphol-2-one (7b): Yield: 79%; 
Mol.Wt: 284; m.p. 125-127 °C; 
lH NMR (500 MHz, DMSO-d6) (δ ppm): 7.90 (d, 2H, J= 8.4 Hz, H-3
l 
&
 H-5
l), 7.60 (d, 2H, J= 8.8 Hz, H-2
l &
 H-6
l), 3.32-3.39 (m, 2H, 
 H-7), 3.06-3.12 (m, 1H, H-3a), 2.81-
2.88 (m, 2H, H-4), 1.43-1.66 (m, 4H, H-5
 &
 H-6); 
13C NMR (125 MHz, DMSO-d6) (δ ppm): 148.3 (C-
1
l), 144.4 (C-4
l), 135.5 (C-3
l & C-5
l), 129.3 (C-2
l & C-6
l), 58.6 (C-7),  47.8 (C-3a), 44.5 (C-4), 33.2 
(C-6), 27.2 (C-5); 
31P NMR (202 MHz, DMSO-d6) (δ ppm): 24.53; IR (KBr) cm
-1: 1251 (P=O), 1212 
(P-O-CAr), 955 (P-O-CAr); LCMS m/z (%): 284[M
+•] (72), 201(52), 146 (40). Analysis (% calculated/ 
found) for C11H13N2O5P: C: 46.49/ 46.44, H: 4.61/ 4.55, N: 9.86/ 9.78. 
 
(3aS)-2-(4-bromophenoxy)perhydro-2λ
5-pyrrolo[1,2-c][1,3,2]oxazaphosphol-2-one  (7c):  Yield:  75%; 
Mol.Wt: 318; m.p. 138-140 °C; 
lH NMR (500 MHz, DMSO-d6) (δ ppm): 7.55 (d, 2H, J= 8.4 Hz, H-3
l 
&
 H-5
l), 7.18 (d, 2H, J= 8.8 Hz, H-2
l &
 H-6
l), 3.35-3.42 (m, 2H, H-7), 3.10-3.17 (m, 1H, H-3a),  2.84-
2.89 (m, 2H, H-4),  1.45-1.66 (m, 4H, H-5
 &
 H-6); 
31P NMR (202 MHz, DMSO-d6) (δ ppm): 22.31; IR 
(KBr) cm
-1: 1253 (P=O), 1215 (P-O-CAr), 959 (P-O-CAr). 
 
(3aS)-2-(2
l,4
l-dichlorophenoxy)perhydro-2λ
5-pyrrolo[1,2-c][1,3,2]oxazaphosphol-2-one (7d):  Yield: 
79%; Mol.Wt: 308; m.p. 121-123 °C; 
lH NMR (500 MHz, DMSO-d6) (δ ppm): 7.23 (s, 1H, H-3
l), 7.18  
(d, 1H, J= 7.5 Hz, H-6
l), 7.13 (d, 1H, J= 7.8 Hz, H-5
l), 3.30-3.37 (m, 2H, H-7), 3.08-3.13 (m, 1H, H-
3a), 2.82-2.90 (m, 2H, H-4), 1.45-1.62 (m, 4H, H-5
 &
 H-6); 
31P NMR (202 MHz, DMSO-d6) (δ ppm): 
21.58; IR (KBr) cm
-1: 1243 (P=O), 1220 (P-O-CAr), 958 (P-O-CAr). 
 
(3aS)-2-(3-pyridyloxy)perhydro-2λ
5-pyrrolo[1,2-c][1,3,2]oxazaphosphol-2-one  (7e):  Yield:  75%; 
Mol.Wt: 240; m.p. 127-129 °C; 
lH NMR (500 MHz, DMSO-d6) (δ ppm): 7.24- 8.32 (m, 4H, Ar-H), 
3.33-3.41 (m, 2H, H-7), 3.09-3.13 (m, 1H, H-3a), 2.81-2.92 (m, 2H, H-4), 1.46-1.64 (m, 4H, H-5
 &
 H-
6);
 13C NMR (125 MHz, DMSO-d6) (δ ppm):  146.6 (C-1
l), 139.5 (C-2
l), 135.3 (C-4
l), 125.8 (C-6
l), 
122.7 (C-5
l), 57.7 (C-7)  45.8 (C-3a), 42.4 (C-4), 32.2 (C-6), 26.9 (C-5); 
31P NMR (202 MHz, DMSO-
d6) (δ ppm): 20.51; IR (KBr) cm
-1: 1248 (P=O), 1218 (P-O-CAr), 964 (P-O-CAr); LCMS m/z (%): 240 
[M
+•] (76), 157(57), 146 (38); Analysis (% calculated/ found) for C10H13N2O3P: C: 50.00/ 49.85, H: 
5.46/ 5.42, N: 11.66/ 11.60. 
 
(3aS)-N,N-bis(2-chloroethyl)octahydro-2λ
5-pyrrolo-[1,2-c][1,3,2]oxazaphosphol-2-one  (7f):  Yield: 
80%;  Mol.Wt:  287;  m.p.  127-129  °C; 
lH  NMR  (500  MHz,  DMSO-d6)  (δ  ppm):  4.16  (t,  4H, 
NCH2CH2Cl J = 13.5 Hz), 3.30 (t, 4H, NCH2CH2-Cl, J = 13.5 Hz), 3.28-3.35 (m, 2H, H-7), 3.00-3.07 
(m, 1H, H-3a), 2.80-2.87 (m, 2H, H-4), 1.46-1.64 (m, 4H, H-5
 &
 H-6); 
31P NMR (202 MHz, DMSO-
d6) (δ ppm): 22.50; IR (KBr) cm
-1: 1231 (P=O), 1211 (P-O-CAr), 960 (P-O-CAr). 
 
Ethyl  2-[(3aS)-1-oxoperhydro-2λ
5-pyrrolo[1,2-c][1,3,2]oxazaphosphol-2-yl]amino-2-  (4-hydroxy 
phenyl) acetate (7g): Yield: 73%; Mol.Wt. 340; m.p. 135-137 °C; 
lH NMR (500 MHz, DMSO-d6) (δ 
ppm): 9.90 (s, 1H, Ar-OH), 7.12 (d, 2H, J= 8.3 Hz, Ar-H), 6.76 (d, 2H, J= 9.0 Hz, Ar-H), 3.89 (d, 1H, 
J= 8.2 Hz, NH-CH-C=O), 3.80 (q, 2H, -OCH2 J= 7.4 Hz), 3.32 (s, 1H, NH), 3.36-3.42 (m, 2H, H-7), 
3.12-3.20 (m, 1H, H-3a),  2.85-2.92 (m, 2H, H-4), 1.34-1.58 (m, 4H, H-5
 &
 H-6), 1.12-1.34 (3H, t, J= 
7.4 Hz, -CH3);
 13C NMR (125 MHz, DMSO-d6) (δ ppm): 168.7 (O=C-O), 152.9 (C-4
l ), 131.7 (C-1
l), 
125.2 ( C-2
l  & C-6
l), 120.6 ( C-3
l  & C-5
l), 63.6 (O-CH2-CH3), 60.4 (C-7), 55.0 (C-3a), 47.8 (NH-CH), 
43.1 (C-4), 29.2 (C-6), 24.7 (C-5), 22.3 (O-CH2-CH3); 
31P NMR (202 MHz, DMSO-d6) (δ ppm): -
17.52; IR (KBr) cm
-1: 3354 (NH), 1728 (C=O), 1239 (P=O). 
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Ethyl  2-[(3aS)-1-oxoperhydro-2λ
5-pyrrolo[1,2-c][1,3,2]oxazaphosphol-2-yl]amino-3-(4-hydroxy 
phenyl)propanoate (7h): Yield: 78%; Mol.Wt: 354; m.p. 139-141 °C; 
lH NMR (500 MHz, DMSO-d6) 
(δ ppm): 10.20 (s, 1H, Ar-OH), 7.10 (d, 2H, J= 9.0 Hz, Ar-H), 6.66 (d, 2H, J= 8.4 Hz, Ar-H), 4.02 (t, 
1H, J= 8.1 Hz, NH-CH-CH2), 3.88 (q, 2H, J= 7.6 Hz -OCH2), 3.78-3.74 (m, 2H, NH-CH-CH2), 3.32 
(1H, s, NH), 3.34-3.39 (m, 2H, H-7), 3.09-3.17 (m, 1H, H-3a), 2.79-2.84 (m, 2H, H-4), 1.36-1.48 (m, 
4H, H-5
 &
 H-6), 1.12 (t, 3H, -CH3); 
13C NMR (125 MHz, DMSO-d6) (δ ppm): 168.8 (O=C-O), 153.4 
(C-4
l ), 132.2 (C-1
l), 125.8 ( C-2
l  & C-6
l), 121.0 ( C-3
l  & C-5
l), 63.9 (O-CH2-CH3), 60.2 (C-7), 55.2 
(C-3a), 47.3 (NH-CH), 43.4 (C-4), 36.4 (NH-CH-CH2), 29.6 (C-6), 24.8 (C-5) 22.5 (O-CH2-CH3); 
31P 
NMR (202 MHz, DMSO-d6) (δ ppm): -20.93; IR (KBr) cm
-1: 3365 (NH), 1735 (C=O), 1228 (P=O); 
LCMS  m/z  (%):  354  [M
+•]  (80),  309  (35),  146  (30);  Analysis  (%  calculated/  found)  for 
C16H23N2O5P: C: 54.23/ 54.18, H: 6.54/ 6.50, N: 7.91/ 7.87. 
 
Methyl  2-[(3aS)-1-oxoperhydro-2λ
5-pyrrolo[1,2-c][1,3,2]oxazaphosphol-2-yl]amino-3-  (1H-3-
indolyl)propanoate (7i): Yield: 74%; Mol.Wt: 363; m.p. 129-131 °C; 
lH NMR (500 MHz, DMSO-d6) 
(δ ppm): 10.85 (br s, 1H, NH), 7.20-7.01 (m, 5H, Ar-H), 3.92 (m, 1H, NH-CH-CH2), 3.56 (q, 2H, OCH2 
J= 7.4 Hz), 3.35 (s, 1H, NH), 3.28-3.34 (m, 2H, H-7), 3.05-3.11 (m, 1H, H-3a), 2.80-2.85 (m, 2H, H-
4), 1.34-1.58 (m, 4H, H-5
 &
 H-6),
 1.23 (t, 3H, OCH2-CH3 J= 7.4 Hz); 
31P NMR (202 MHz, DMSO-d6) 
(δ ppm): -22.28; IR (KBr) cm
-1: 3326 (NH), 1742 (C=O), 1232 (P=O); Analysis (% calculated/ found) 
for C17H22N3O4P: C: 56.20/ 56.17, H: 6.10/ 6.06, N: 11.56/ 11.49. 
 
Benzyl(2R)-1-[(3aS)-1-oxoperhydro-2λ
5-pyrrolo[1,2-c][1,3,2]oxazaphosphol-2-yl] tetrahydro -1H-2-
pyrrolecarboxylate (7j):  Yield: 73%; Mol.Wt: 350; m.p. 140-142 °C; 
lH NMR (500 MHz, DMSO-d6) 
(δ ppm): 7.52-7.35 (m, 5H, Ar-H), 5.28 (s, 2H, Ar-CH2), 3.25-3.38 (m, 1H, N-CH-C=O), 3.22-3.36 
(m, 2H, H-7), 3.12-3.18 (m, 1H, 3a), 2.85-2.94 (m, 4H, H-4 & H-5
l), 1.82-2.08 (m, 2H, H-3
l), 1.25-
1.65 (m, 6H, H-5, H-6 & H-4
l); 
31P NMR (202 MHz, DMSO-d6) (δ ppm): -19.56; IR (KBr) cm
-1: 3378 
(NH),1758 (C=O), 1225 (P=O). 
 
Ethyl2-[(3aS)-1-oxoperhydro-2λ
5-pyrrolo[1,2-c][1,3,2]oxazaphosphol-2-yl]amino-3-(1H--imidazoyl) 
propanoate (7k): Yield: 82%; Mol.Wt: 328; m.p. 145-147 °C; 
lH NMR (500 MHz, DMSO-d6) (δ 
ppm): 11.20 (br s, 1H, NH), 8.73 (s, 1H, NH-CH=N-), 7.66 (s, 1H, NH-CH=C-), 5.02 (m, 1H , NH-CH-
CH2), 3.72 (t, 2H, O-CH2-CH3 J= 7.6 Hz),  3.28-3.34 (m, 2H, H-7), 3.16-3.24 (m, 1H, N-CH-C=O), 
3.08 (d, 2H, J= 8.5 Hz, NH-CH-CH2), 2.91-2.97 (m, 1H, H-3a), 2.65-2.72 (m, 2H, H-4), 1.34-1.58 (m, 
4H, H-5
 &
 H-6), 1.21 (t, 3H, O-CH2-CH3 J= 7.6 Hz);
 31P NMR (202 MHz, DMSO-d6) (δ ppm): -20.51; 
IR (KBr) cm
-1: 3382 (NH), 1743 (C=O), 1239 (P=O). 
 
Ethyl  2-[(3aS)-1-oxoperhydro-2λ
5-pyrrolo[1,2-c][1,3,2]oxazaphosphol-2-yl]amino  -3-(phenyl) 
acetate  (7l):  Yield:  75%;  Mol.Wt:  324;  m.p.  127-129  °C;  Anal:  Calcd.  for  C10H13N2O3P:  C, 
50.00.20; H, 5.46; N, 11.66. Found: C, 49.75; H, 5.43; N, 11.60; 
lH NMR (500 MHz, DMSO-d6) (δ 
ppm): 6.83- 7.12 (m, 5H, Ar-H), 4.61-4.69 (m, 1H, NH-CH-C=O), 3.45 (q, 2H, -OCH2-CH3, J=7.4 Hz), 
3.35-3.41 (m, 2H, H-7), 3.32 (s, 1H, NH), 3.11-3.20 (m, 1H, H-3a), 2.84-2.92 (m, 2H, H-4),  1.34-1.58 
(m, 4H, H-5
 &
 H-6),  1.12 (t, 3H, -OCH2-CH3, J= 7.4 Hz); 
 31P NMR (202 MHz, DMSO-d6) (δ ppm): δ 
-21.31; IR (KBr) cm
-1: 3394 (NH), 1756 (C=O), 1248 (P=O); LCMS m/z (%): 324[M
+•] (74), 279 
(35), 148 (28). 
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4.2.  Agar dilution method for MIC 
 
 
The minimum inhibitory concentration (MIC) was evaluated by using agar dilution technique. 
Agar dilution MIC tests were performed according to standard method.
17 The lowest concentration of 
title compound showing no growth was read as the MIC. Staphylococcus aureus, Bacillus subtilis, 
Klebsiella pneumoniea and Escherichia coli  were included in each run.  
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